References
- Leal AM, Moreira AC. Food and the circadian activity of the hypothalamic-pituitary-adrenal axis. Braz J Med Biol Res 1997; 30(12): 1391–405.
- Tannenbaum BM, Brindley DN, Tannenbaum GS, Dallman MF, McArthur MD, Meaney MJ. High-fat feeding alters both basal and stress-induced hypothalamic-pituitary-adrenal activity in the rat. Am J Physiol 1997; 273(6 Pt 1): S1168–S77.
- Dallman MF, Akana SF, Strack AM, Hanson S, Sebastian RJ. The neural network that regulates energy balance is responsive to glucocorticoids and insulin and also regulates HPA axis responsivity at sites proximal to CRF neurons. Ann NYAcad Sci 1995; 771: 730–42.
- Merali Z, Mcintosh J, Kent P, Michaud D, Anisman H. Aversive and appetitive events evoke the release of corticotropinreleasing hormone and bombesin-like peptides at the central nucleus of the amygdala. J Neurosci 1998; 18(12): 4758–66.
- Pecoraro N, Reyes F, Gomez F, Bhargava A, Dallman MF. Chronic stress promotes palatable feeding, which reduces signs of stress: feedforward and feedback effects of hronic stress. Endocrinology 2004; 145(8): 3754–62.
- Koob GF, Heinrichs SC. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res 1999; 848(1–2): 141–52.
- Ahima RS, Flier JS: Leptin. Annu Rev Physiol 2000; 62: 413–37.
- Ueta Y, Ozaki Y, Saito J, Onaka T. Involvement of novel feeding- related peptides in neuroendocrine response to stress. Exp Biol Med 2003; 228(10): 1168–74.
- Spinazzi R, Andreis PG, Rossi GP, Nussdorfer GG. Orexins in the regulation of the hypothalamic-pituitary-adrenal axis. Pharmacol Rev 2006; 58(1): 46–57.
- Emul HM, Serteser M, Kurt E, Ozbulut O, Guler O, Gecici O. Ghrelin and leptin levels in patients with obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31(6): 1270–4.
- Anisman H, Merali Z, Hayley S. Neurotransmitter, peptides and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders. Prog Neurobiol 2008; 85(1): 1–74.
- Liu J, Garza JC, Truong HV, Henschel J, Zhang W, Lu XY. The melanocortinergic pathway is rapidly recruited by emotional stress and contributes to stress-induced anorexia and anxiety-like behavior: Endocrinology 2007; 148(11): 5531–40.
- Oh I, Shimizu H, Satoh T, Okada S, Adachi S, Inoue K, et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 2006; 443(7112): 709–12.
- Brailoiu GC, Dun SL, Brailoiu E, Inan S, Yang J, Chang JK, et al. Nesfatin-1: distribution and interaction with a G protein coupled receptor in the rat brain. Endocrinology 2007; 148(10): 5088–94
- Merali Z, Cayer C, Kent P, Anisman H. Nesfatin-1 increases anxiety- and fear-related behaviors in the rats. Psychopharmacology 2008; 201(1): 115–23.
- Ari M, Ozturk OH, Bez Y, Oktar S, Erduran E. High plasma nesfatin-1 level in patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35(2): 497–500.
- Bez Y, Ari M, Ozturk OH, Oktar S, Can Y, Sogut S. Plasma nesfatin-1 level may be associated with disease severity in patients with panic disorder. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 2010; 20(4): 288–92.
- Goodman WK, Price LH, Rasmussen SA. The Yale-Brown Obsessive Compulsive Scale. Arch Gen Psychiatry 1989; 46(11): 1006–16.
- Aydin S, Dag E, Ozkan Y, Erman F, Dagli AF, Kilic N, et al. Nesfatin-1 and ghrelin levels in serum and saliva of epileptic patients: hormonal changes can have a major effect on seizure disorders. Mol Cell Biochem 2009; 328(1–2): 49–56.
- Tsuchiya T, Shimizu H, Yamada M, Osaki A, Oh-I S, Ariyama Y, et al. Fasting concentrations of nesfatin-1 are negatively correlated with body mass index in non-obese males. Clin Endocrinol (Oxf) 2010; 73(4): 484–90.
- Goebel M, Stengel A, Wang L, Taché Y. Restraint stress activates nesfatin-1-immunoreactive brain nuclei in rats. Brain Res 2009; 1300: 114–24.
- Price CJ, Samson WK, Ferguson AV. Nesfatin-1 inhibits NPY neurons in the arcuate nucleus. Brain Res 2008; 1230: 99–106.
- Ramanjaneya M, Chen J, Brown JE, Tripathi G, Hallschmid M, Patel S, et al. Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity. Endocrinology 2010; 151(7): 3169–80.
- Pan W, Hsuchou H, Kastin AJ. Nesfatin-1 crosses the blood-brain barrier without saturation. Peptides 2007; 8(11): 2223–8.
- Price TO, Samson WK, Niehoff ML, Banks WA. Permeability of the blood-brain barrier to a novel satiety molecule nesfatin-1. Peptides 2007; 28(12): 2372–81.